Publications:

Prognostic Biomarkers on a Competitive Endogenous RNA Network Reveals Overall Survival in Triple-Negative Breast Cancer.

Frontiers In Oncology

Qin, Wenxing W; Qi, Feng F; Li, Jia J; Li, Ping P; Zang, Yuan-Sheng YS

Publication Date: 2021

Variant appearance in text: HER2: A14C

PubMed Link: 34178671

Variant Present in the following documents:

• Main text

View BVdb publication page

Targeting transcription of MCL-1 sensitizes HER2-amplified breast cancers to HER2 inhibitors.

Cell Death & Disease

Floros, Konstantinos V KV; Jacob, Sheeba S; Kurupi, Richard R; Fairchild, Carter K CK; Hu, Bin B; Puchalapalli, Madhavi M; E Koblinski, Jennifer J; Dozmorov, Mikhail G MG; Boikos, Sosipatros A SA; Scaltriti, Maurizio M; Faber, Anthony C AC

Publication Date: 2021-02-15

Variant appearance in text: HER2: A14C

PubMed Link: 33589591

Variant Present in the following documents:

• Main text

View BVdb publication page

ClpP regulates breast cancer cell proliferation, invasion and apoptosis by modulating the Src/PI3K/Akt signaling pathway.

Peerj

Luo, Juan J; Zeng, Beilei B; Tao, Chunfang C; Lu, Mengqi M; Ren, Guosheng G

Publication Date: 2020

Variant appearance in text: HER2: A14C

PubMed Link: 32195060

Variant Present in the following documents:

• peerj-08-8754-s034.xlsx, sheet 3
• peerj-08-8754-s034.xlsx, sheet 2

View BVdb publication page